Mentice Inc.

28 articles with Mentice Inc.

• Thomas Jefferson University Hospitals and Mentice to establish a Simulation Center of Excellence for Interventional Radiology

  6/9/2021

  Thomas Jefferson University Hospitals and Mentice have formed a strategic collaboration to establish a Simulation Center of Excellence uniting Jefferson's world-class interventional radiology team with Mentice's virtual patient technology aiming to elevate clinical training and to introduce advanced Virtual Reality simulation solutions for physicians in clinical practice.

• Communique from annual general meeting in Mentice AB (publ)

  5/6/2021

  An annual general meeting was held in Mentice AB on 6 May 2021.

• Mentice publishes the company's interim report for the period January-March 2021

  4/28/2021

  Continued strong order intake, with the strongest order intake figure for a first quarter in Mentice's history on the back end of our strongest order intake for a fourth quarter ever.

• Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on April 28 at 9:30 CET

  4/21/2021

  Mentice AB announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund.

• Mentice appoints Pontus Appelqvist as Vice President and GM for Asia Pacific

  4/15/2021

  Mentice AB, a leading supplier of high-tech solutions for simulation in the medical sector, with a focus on endovascular procedures, announced the appointment of Pontus Appelqvist as Vice President and General Manager for Asia Pacific.

• Notice to attend the Annual shareholders' meeting in Mentice AB

  4/8/2021

  The shareholders of Mentice AB, reg. no. 566556-4241, are hereby given notice to attend the annual shareholders' meeting to be held on 6 May 2021 by completing a form for postal voting.

• Mentice publishes the company's year-end report for the period January-December 2020

  2/4/2021

  Strong order intake and substantial improvement of the company's order book as well as operating cash flow Fourth quarter

• Mentice's CEO Göran Malmberg to present the company's year-end 2020 report at a webcast conference call on February 4 at 9:30 CET

  1/29/2021

  Mentice AB announces that the company will present its year-end report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund.

• Mentice to enhance its organization with several new key positions

  1/13/2021

  Mentice AB, a leading supplier of high-tech solutions for simulation in the medical sector, with focus on endovascular procedures, has announced changes to its organization.

• Issuance of new shares in Mentice AB (publ) has been registered with the Swedish Companies Registration Office

  12/4/2020

  Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price of SEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at a subscription price of SEK 84.28.

• Mentice to Acquire Vascular Simulations

  10/1/2020

  - Combined portfolio will enhance Mentice's endovascular simulation offerings with world class replication solutions - Acquisition to expand Mentice's global customer base and offer a strong entry into previously untapped market segments

• Mentice Appoints Thanos Karras as Americas General Manager to Accelerate Group's Growth Strategy

  7/1/2020

  Mentice AB announced the appointment of Thanos Karras as the company's new General Manager for Americas.

• Mentice Expands its Coronary Product Portfolio With an Advanced Software Solution for Coronary Interventions

  5/21/2020

  Coronary Advanced to Help Fellows and Attending Interventional Cardiologists to Perfect Skills in Complex Scenarios

• Mentice Launches Seventh Generation Platform Aimed to Transform Endovascular Therapy

  5/19/2020

  VIST® G7 Brings Reality to Complex Interventions and Introduces a Scalable and Flexible Platform for Advanced Future Applications

• Mentice Expands Coronary Product Portfolio with the Introduction of Coronary Intermediate Software

  3/12/2020

  Mentice AB, a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio.

• Mentice Showcases First-of-Its-Kind Flexible Coronary Training Solution at IMSH 2020

  1/13/2020

  Mentice AB, a world leader in simulation solutions for endovascular therapies, will be showcasing the first of-its-kind flexible Coronary Essentials training solution at the 20th International Meeting on Simulation in Healthcare in San Diego from January 19 to January 22.

• Mentice Introduces its Advanced, High-fidelity VIST® One TEE Echocardiography Training Solution at TCT Symposium 2019

  9/16/2019

  Featuring real-time 2D and 3D echo and multiplanar reconstruction, VIST® One TEE is the most sophisticated TEE Training solution available in the market today. 

• Mentice Introduces Today Subscription-based Pricing for its Endovascular-Simulation Training Software

  8/6/2019

  Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, announces today the introduction of software subscription for its VIST® endovascular simulation platform to hospitals and health systems.

• Endovascular Simulation Specialist Mentice Appoints Chief Clinical Officer

  1/9/2019

  Mentice today announced the appointment of Dr. David J. Ballard as Chief Clinical Officer and Executive Vice President of the Mentice Group.

• Mentice Appoints New Member to its Board of Directors.

  10/24/2018

  Mentice announced today the appointment of a new independent member to its Board of Directors.